Clinical experiences for fellows comprise a total of one-third of the 3-year training program and occur at the Sheikh Zayed Campus for Advanced Children's Medicine of Children's National Health System in Washington, DC. Children's Hospital is a 313-bed facility that has served the nation's capital for over 140 years. Included in these beds are a Level IIIC Neonatal Intensive Care Unit, a Pediatric Intensive Care Unit, a Cardiac Intensive Care Unit, a Neurologic Intensive Care Unit, a Hematopoietic Stem Cell Transplant Unit, and a Level I Trauma Center. We admit over 13,000 children annually and provide more than 350,000 outpatient visits per year. Our Infectious Diseases service sees approximately 30 new and 100 follow-up visits monthly in our outpatient clinic, with over 100 inpatient consult visits per month. We accept up to three new fellows into the program each year.
Our infectious diseases practice reflects a highly diverse patient population, with children residing in the mid-Atlantic region as well as those originating or traveling from sites across the United States and the world. We care for children with not only common pediatric infections such as pneumonia and osteomyelitis, but also conditions including malaria, typhoid fever, and other tropical diseases, endemic infections such as Lyme Disease and Rocky Mountain Spotted Fever, and infections in compromised hosts. Our fellows actively participate in our Special Immunology Service, providing subspecialty and primary care to HIV-exposed and infected children.
Combined Internal Medicine-Pediatrics Infectious Disease Fellowship
In conjunction with Dr. Tara Palmore, Fellowship Director of the Infectious Diseases Fellowship at the National Institutes of Health, we are accepting applications from highly qualified graduates of US and Canadian internal medicine-pediatrics residencies for our 4-year fellowship program. The fellow would spend 1 year each in clinical pediatric infectious diseases and clinical adult infectious diseases, with the remaining 2 years of training focusing on a research topic chosen by the fellow. Interested applicants should contact Dr. Wiedermann directly at firstname.lastname@example.org.
Research experience is performed for 2 years out of the 3-year fellowship program. All fellows choose a Scholarly Activity resulting in a work product in accordance with American Board of Pediatrics requirements. The program provides access to a wide variety of opportunities for this major project. Additionally, most fellows also complete smaller research projects for publication, such as descriptive case series, retrospective case control studies, or prospective interventional studies, and present study findings at national meetings.
Fellows in this track usually will complete a scholarly activity in clinical/translational or bench research, in any of a number of broad areas of focus in general or HIV-related infectious diseases, immunology, microbiology, or related fields. Opportunities for research related to global health and epidemiology/infection control also are possible. Fellows will work with ID attendings to identify research projects and mentor(s) within and/or external to the ID Division, such as, but not limited to Children’s Research Institute, the National Institutes of Health, George Washington University, and Walter Reed Medical Center. Rich opportunities, state-of-the-art research facilities, and infrastructural support are present on-site at the Children's Research Institute for the pursuit of a wide range of clinical, basic science, epidemiologic and outcomes research. Our Clinical and Translational Science Institute with pediatric Clinical Research Center is integrated within CNMC, facilitating close relationships between investigators and clinicians, and research by physician scientists.
In the FDA Tracks, the Scholarly Activity is based on the fellow's major review endeavors at the FDA, either related to antimicrobial agents (CDER fellow) or vaccines (CBER fellow). For both CDER and CBER fellows, most of the research time is spent on the FDA campus, with primary focus of reviewing a new product for possible FDA approval. These work products represent a comprehensive study of a new product, with a report considerably longer and more detailed than a journal article.
Fellows review animal data, pharmacology, clinical trial protocols, and other data under the mentorship of CDER physicians, biostatisticians, and other personnel, for new antimicrobial agents submitted for approval. CDER fellows work in the Division of Anti-Infective Products and in the Division of Antiviral Products, housed within FDA's Office of Antimicrobial Products. Download an overview of the CDER curriculum
Fellows review scientific data for consideration of licensing of new vaccines and biologics under the mentorship of CBER physicians, biostatisticians, and other personnel. CBER fellows work in the Office of Vaccines Research and Review. Download an overview of the CBER curriculum